Literature DB >> 3859925

Pharmacokinetics and cellular determinants of response to 1-beta-arabinofuranosylcytosine (ara-C).

C M Riva, Y M Rustum, H D Preisler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3859925

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  3 in total

Review 1.  Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens.

Authors:  W Hiddemann
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

2.  Chemotherapy with cytosine arabinoside in a child with Burkitt's lymphoma on maintenance hemodialysis and hemofiltration.

Authors:  J M Pöschl; G Klaus; U Querfeld; R Ludwig; O Mehls
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

3.  Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B study.

Authors:  R A Fleming; R L Capizzi; G L Rosner; L K Oliver; S J Smith; C A Schiffer; R T Silver; B A Peterson; R B Weiss; G A Omura
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.